IIM Bodh Gaya hosts ‘Convergence 2.0’ on re-imagining India’s healthcare with emerging technologies

Indian Institute of Management Bodh Gaya (IIM Bodh Gaya) organised ‘Convergence 2.0’ to discuss the development of the healthcare landscape with the help of emerging technologies. Themed at ‘Re-imagining Healthcare Ecosystem with Technological Advancements’, the event witnessed participation from industry leaders, policymakers, clinicians and innovators.

During the event, held today, the experts shared practical insights on emerging technologies that are reshaping the healthcare landscape. Followed by a series of panel discussions led by senior practitioners and thought leaders then examined key aspects of the healthcare ecosystem , according to the official statement by IIM Bodh Gaya .

Healthcare industry experts such as Ajay Bagga, MD & Country Head, Zimmer Biomet; Manish Sardana, MD & GM, South Asia, Vygon; Ram Panda, MD, Healthcare & Life Sciences, Alvarez & Marsal; Bhupendra Tripathi, Deputy Director, Gates Foundation; Pragati Awasthi, Group VP, Romsons Group; Lalit Kanodia, VP, Hospitals & Corporate Services, Tata 1mg; and Anith Sankaran, Head of Supply Chain, Shalby MedTech took part in the panel discussion.

Also read ‘We are reimagining MBA education’: IIM Bangalore dean

MBA in Hospital and Healthcare Management

Emphasising the need of an India-Specific Healthcare vision, Vinita S Sahay, director of IIM Bodh Gaya said: “India cannot afford healthcare the way the West does. What we need is a nation that is well, healthy, and strong in body and spirit.”

Swapnarag Swain, chairperson MBA (Hospital & Healthcare Management) IIM Bodh Gaya, stated the purpose of the leadership summit and said: “The event is held to establish a strong and continued exchange of knowledge between academia and industry. The remarks framed the summit’s focus on scalable, equitable solutions and set the tone for the discussions that followed.”

In addition, IIM Bodh Gaya is committed to shaping its MBA in Hospital and Healthcare Management (HHM) programme as a highly industry-centric, practice-oriented course aligned with the evolving needs of the healthcare sector, the management institute said.

It also highlighted the need to establish a strong and continued exchange of knowledge between academia and industry.

Topics in the panel discussion included the pharmaceutical and life-sciences sector, supply-chain resilience, affordability and access to innovative therapies, the role of clinical trials, and emerging trends in vaccines, immunotherapy and personalised medicine. “Discussions covered AI-driven diagnostics, telemedicine, connected medical devices and data intelligence, and produced actionable recommendations for improving interoperability, strengthening supply chains and promoting responsible adoption of new technologies,” the official statement reads.